# FDA Inspection 722033 - Actavis South Atlantic LLC - April 28, 2011

Source: https://www.keypedia.com/records/fda_inspections/actavis-south-atlantic-llc/cb1269b8-7720-449d-b557-ba9bf6de7d63
Source feed: FDA_Inspections

> FDA Inspection 722033 for Actavis South Atlantic LLC on April 28, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 722033
- Company Name: Actavis South Atlantic LLC
- Inspection Date: 2011-04-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 783911 - 2012-04-25](https://www.keypedia.com/records/fda_inspections/actavis-south-atlantic-llc/8c66aa01-f836-4b58-922d-f6a5c5ec2609)
- [FDA Inspection 783901 - 2012-04-19](https://www.keypedia.com/records/fda_inspections/actavis-south-atlantic-llc/891deaac-a399-4519-80b4-e14a639feb03)
- [FDA Inspection 611626 - 2009-08-19](https://www.keypedia.com/records/fda_inspections/actavis-south-atlantic-llc/57339476-8499-45e4-96d8-62f9082f86c2)

Company: https://www.keypedia.com/companies/actavis-south-atlantic-llc/9cd1f52b-acbd-437a-bb93-c41ac0d6ebe7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c